What is the recommended dosing for Losartan (angiotensin II receptor antagonist)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Losartan Dosing Recommendations

The recommended starting dose of losartan is 50 mg once daily, which can be increased to a maximum dose of 100 mg once daily as needed to control blood pressure. 1

Standard Dosing for Different Indications

Hypertension

  • Initial dose: 50 mg once daily 1
  • Maximum dose: 100 mg once daily 1
  • Starting dose for patients with possible intravascular depletion (e.g., on diuretic therapy): 25 mg once daily 1

Hypertensive Patients with Left Ventricular Hypertrophy

  • Initial dose: 50 mg once daily 1
  • Titration: Can increase to 100 mg once daily based on blood pressure response 1
  • Additional therapy: Hydrochlorothiazide 12.5 mg daily can be added and increased to 25 mg daily if needed 1

Nephropathy in Type 2 Diabetic Patients

  • Initial dose: 50 mg once daily 1
  • Maximum dose: 100 mg once daily based on blood pressure response 1
  • Evidence suggests: 100 mg daily may be more effective than 50 mg for renoprotection 2

Special Population Considerations

Hepatic Impairment

  • Mild to moderate impairment: Starting dose of 25 mg once daily 1
  • Severe hepatic impairment: Not studied, use with caution 1

Renal Impairment

  • No dosage adjustment is necessary for various degrees of renal insufficiency 3
  • Losartan has been shown to be effective and well-tolerated in patients with chronic renal disease, including those on hemodialysis 4

Pediatric Patients

  • Starting dose: 0.7 mg/kg once daily (up to 50 mg total) 1
  • Maximum dose: 1.4 mg/kg daily (not to exceed 100 mg) 1
  • Not recommended in pediatric patients less than 6 years of age or with eGFR < 30 mL/min/1.73 m² 1

Optimal Dosing Considerations

  • Evidence suggests that 100 mg daily may be more effective than 50 mg for both blood pressure reduction and renoprotection 2, 5
  • For heart failure patients, higher target doses of losartan (up to 150 mg daily) may provide greater benefits in reducing mortality and heart failure hospitalizations 6
  • The HEAAL trial showed that 150 mg daily of losartan was superior to 50 mg daily for heart failure outcomes 7

Administration Guidelines

  • Losartan can be administered without regard to food 3
  • The pharmacokinetics of losartan are linear and dose-proportional 3
  • After oral administration, losartan is rapidly absorbed, reaching maximum concentrations in 1-2 hours 3
  • Approximately 14% of a losartan dose is converted to the active E3174 metabolite, which is 10-40 times more potent than losartan 3

Monitoring Recommendations

  • Monitor blood pressure within 1-2 weeks after initiation or dose changes 6
  • Evaluate renal function before initiation and periodically during treatment 6
  • Monitor for potential hyperkalemia, especially when combined with other medications affecting the renin-angiotensin system 6

Important Precautions

  • Contraindicated in pregnancy 6
  • Avoid routine combined use of an ACE inhibitor, ARB, and aldosterone antagonist as it is potentially harmful 6
  • Use with caution in patients with severe bilateral renal artery stenosis 6

Losartan is generally well-tolerated with a favorable side effect profile compared to other antihypertensive medications, making it a valuable option for patients who cannot tolerate ACE inhibitors due to cough 8.

References

Research

Optimal dose of losartan for renoprotection in diabetic nephropathy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002

Research

Clinical pharmacokinetics of losartan.

Clinical pharmacokinetics, 2005

Research

Pharmacokinetic evaluation of losartan.

Expert opinion on drug metabolism & toxicology, 2011

Guideline

Management of Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.